Fatty Liver News and Research

Latest Fatty Liver News and Research

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

Diet and exercise fail for most adults who try to lose weight in the long-term. Today the American Gastroenterological Association (AGA) released new evidence-based guidelines strongly recommending that these patients with obesity use recently approved medications paired with lifestyle changes.

20 Oct 2022

BMI: The mismeasure of weight and the mistreatment of obesity

People who seek medical treatment for obesity or an eating disorder do so with the hope their health plan will pay for part of it. But whether it's covered often comes down to a measure invented almost 200 years ago by a Belgian mathematician as part of his quest to use statistics to define the "average man."

12 Oct 2022

Study opens up new approaches for treating fatty liver disease

A study group at MedUni Vienna has identified a regulatory loop controlled by leptin, by which this adipocyte-derived hormone regulates hepatic lipid metabolism via the autonomic nervous system.

11 Oct 2022

Study shows the important role of hepatocyte adenosine kinase in NAFLD progression

A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD.

5 Oct 2022

TGen and ASU partner with Phoenix Children’s and Cincinnati Children’s to better understand NAFLD

The prevalence of nonalcoholic Fatty Liver Disease, NAFLD, is rising in American children, with kids of Latino ancestry being hit disproportionately hard by the disease.

28 Sep 2022

Selectively targeting iGPX4 may be a promising therapeutic strategy for metabolic-associated fatty liver disease

This new article publication from Acta Pharmaceutica Sinica B, discusses targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease.

26 Sep 2022

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

A mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment, according to a new USC study.

21 Sep 2022

Review highlights the role of retinol-binding protein-4 in non-alcoholic fatty liver disease

It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related liver diseases.

13 Sep 2022

New cold perfusion approach to isolate hepatic stellate cells from fatty liver-associated tumors

Obesity can give rise to a variety of health concerns. Nonalcoholic steatohepatitis (NASH)-; a type of fatty liver disease that might progress to cancer-; is particularly prevalent among obese people.

12 Sep 2022

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Using a genetic screening platform developed by a UT Southwestern Nobel Laureate, scientists with the Center for the Genetics of Host Defense at UT Southwestern Medical Center have identified genetic mutations that contribute to nonalcoholic fatty liver disease (NAFLD), providing a potential future target for therapeutic interventions.

9 Sep 2022

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

People who suffer from obstructive sleep apnea (OSA) are at an increased risk of cancer, according to a large study presented on Monday at the European Respiratory Society International Congress in Barcelona, Spain.

5 Sep 2022

New discovery helps explain the dynamics underlying liver damage in type 2 diabetes and obesity

When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that trips these defenses, a discovery that helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity.

19 Aug 2022

Eating grapes may reduce the risk of fatty liver disease

In a recent study published in the journal Foods, eating grapes can extend life expectancy by five years and reduce non-alcoholic fatty liver disease risk in mice fed high-fat diets.

17 Aug 2022

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

The current study, published online in the journal JHEP Reports, looks at PFAS, which are endocrine disruptors and potential hepatotoxins.

11 Aug 2022

Exposure to a synthetic “forever chemical” linked to non-viral hepatocellular carcinoma

Exposure to a synthetic chemical found widely in the environment is linked to non-viral hepatocellular carcinoma, the most common type of liver cancer, according to a new study conducted by researchers from the Keck School of Medicine of USC and published in JHEP Reports.

9 Aug 2022

Grape consumption alters gene expression in the brain and has positive effects on behavior and cognition

Recent studies released by Dr. John Pezzuto and his team from Western New England University show "astonishing" effects of grape consumption and "remarkable" impacts on health and on lifespans.

9 Aug 2022

Vitamin B12, folic acid supplements could potentially halt or reverse advanced form of fatty liver disease

Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease-;and it turns out that vitamin B12 and folic acid supplements could reverse this process.

5 Aug 2022

Using native microbes as chassis for transgene delivery in live bacterial therapeutics

Residing within the human gut are trillions of bacteria and other microorganisms that can impact a variety of chronic human ailments, including obesity, type 2 diabetes, atherosclerosis, cancer, non-alcoholic fatty liver disease and inflammatory bowel disease.

4 Aug 2022

Mice study reveals hepatic consequences of exposure to endocrine disrupting chemical mixtures

We are increasingly being exposed to endocrine-disrupting chemicals (EDCs) that interfere with the normal functioning of our hormones. Bisphenol A (BPA) and phthalates, which are widely used in consumer products including plastics, aluminum cans, pharmaceuticals, and cosmetics, are well-known EDCs.

4 Aug 2022

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

In this interview, we speak to Tom Kostrzewski, VP of Science and Technology at CN Bio, about their organ-on-a-chip product and the future of drug discovery.

From CN-Bio 3 Aug 2022

Fatty Liver News and Research

Latest Fatty Liver News and Research

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

BMI: The mismeasure of weight and the mistreatment of obesity

Study opens up new approaches for treating fatty liver disease

Study shows the important role of hepatocyte adenosine kinase in NAFLD progression

TGen and ASU partner with Phoenix Children’s and Cincinnati Children’s to better understand NAFLD

Selectively targeting iGPX4 may be a promising therapeutic strategy for metabolic-associated fatty liver disease

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

Review highlights the role of retinol-binding protein-4 in non-alcoholic fatty liver disease

New cold perfusion approach to isolate hepatic stellate cells from fatty liver-associated tumors

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

New discovery helps explain the dynamics underlying liver damage in type 2 diabetes and obesity

Eating grapes may reduce the risk of fatty liver disease

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

Exposure to a synthetic “forever chemical” linked to non-viral hepatocellular carcinoma

Grape consumption alters gene expression in the brain and has positive effects on behavior and cognition

Vitamin B12, folic acid supplements could potentially halt or reverse advanced form of fatty liver disease

Using native microbes as chassis for transgene delivery in live bacterial therapeutics

Mice study reveals hepatic consequences of exposure to endocrine disrupting chemical mixtures

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Fatty Liver News and Research

Latest Fatty Liver News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in